Skip to main content

Rockwell Medical Value Stock - Dividend - Research Selection

Rockwell medical

ISIN: US7743741024 , WKN: 916118

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company\'s lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient\'s bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company\'s target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Rockwell Medical Promotes Tim Chole to Chief Commercial Officer

2024-05-30
WIXOM, Mich., May 30, 2024--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.

Analysts Offer Insights on Healthcare Companies: Innovative Eyewear, Inc. (LUCY), Rockwell Med (RMTI) and Mereo Biopharma Group Plc (MREO)

2024-05-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Rockwell Medical: Strong Financial Performance and Strategic Partnerships Justify Buy Rating

2024-05-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Rockwell Medical Inc (RMTI) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

2024-05-15
Amidst financial challenges, Rockwell Medical Inc (RMTI) showcases a robust sales increase and strategic market expansions in Q1 2024.

Q1 2024 Rockwell Medical Inc Earnings Call

2024-05-15
Q1 2024 Rockwell Medical Inc Earnings Call

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

2024-05-14
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 60% and 7.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance

2024-05-14
WIXOM, Mich., May 14, 2024--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2024.

RMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024

2024-05-14
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript

2024-05-14

Rockwell Medical: Q1 Earnings Snapshot

2024-05-14
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.